SHINE Medical Technologies one step closer to new production facility

Michael Walter | | Radiology Business | Medical Imaging

SHINE Medical Technologies, a Monona, Wis.-based medical isotope manufacturer, announced this week that the Nuclear Regulatory Commission (NRC) has recommended approval of a construction permit for the company’s medical isotope production facility.

The facility will be used for the production of molybdenum-99 (Mo-99) without highly enriched uranium. It will be located in Janesville, Wis., and employ 150 people.

“This is the first time in over fifty years a medical isotope plant has been recommended for a construction permit,” Greg Piefer, SHINE CEO, said in a statement. “We’ve developed a greener, safer, and cheaper way to produce these isotopes on a global scale. Specifically, these documents are the conclusion of more than four years of hard work and deliberation by both the NRC staff and SHINE. We are tremendously proud to have earned the recommendation of one of the world’s most highly-respected regulators.”

The review process involved numerous reviews by the NRC and a letter from the Advisory Committee on Reactor Safeguards. The next step is a hearing with NRC commissioners.

Last week, SHINE received $1 million in funding from the U.S. Department of Energy’s National Nuclear Security Administration (NNSA) for its work on Mo-99 production.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Radiologists are more accurate, confident when they know the full story
GE HealthCare moves PET/CT scanner production to United States
Use of AI opportunistic screening in CT for cardiovascular disease

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.